Biotech

Revive Therapeutics Announces Positive Results of its Novel Cannabinoid Delivery Technology

TORONTO, ONTARIO: ...

ANGLE plc Announces Circulating Tumour Cells, Harvested From Blood, Grown in the Laboratory for the First Time

GUILDFORD, SURREY: ...

Angle''s Parsortix(TM) System Showcased in Multiple Presentations at Leading European Circulating Tumour Cell Conference

GUILDFORD, UNITED KINGDOM: ...

Theratechnologies Announces Financial Results for Third Quarter of 2017

MONTREAL, QUEBEC: ...

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017(TM)

MONTREAL, QUEBEC: HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab with Optimized Background Regimen Maintained High Viral Suppression and was Well Tolerated Through Week 48 in Patients ...

Critical Outcome Technologies Reports Fiscal 2018 First Quarter Financial and Operating Results

LONDON, ONTARIO and BOSTON, MASSACHUSETTS: ...

Revive Therapeutics Applies to FDA for Orphan Drug Designation for Treatment of Autoimmune Hepatitis

TORONTO, ONTARIO: ...

Realm Therapeutics Announces $26 Million PIPE Financing

MALVERN, PA: ...

Treos Bio Enters into Agreement with PPD to Manage First-in-Man Trial of Its Lead Therapeutic Cancer Vaccine Program

SAN FRANCISCO, CA and LONDON, UNITED KINGDOM: ...

Revive Therapeutics and South Carolina Research Foundation Enter into Exclusive License Agreement for Cannabinoids-Based Therapeutics in the Treatment of Liver Diseases

TORONTO, ONTARIO: ...